[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344744-105":59,"doc-detail-344744-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-emerging-role-of-sphk1-at-the-immune-metabolic-interface-a-pan-cancer-integrative-analysis","The emerging role of SPHK1 at the immune-metabolic interface - a pan-cancer integrative analysis","","Cancer continues to drive rising global morbidity and mortality, with metabolic reprogramming shaping an immunosuppressive tumor microenvironment. Sphingosine kinase 1 (SPHK1) regulates sphingolipid signaling by balancing sphingosine-1-phosphate and sphingosine, influencing cell fate and immune activity. Yet SPHK1’s role as a “metabolic immune checkpoint,” its prognostic relevance, and links to immunotherapy remain unclear. This pan-cancer study integrates TCGA RNA-seq, clinical validation, viability testing, and immunological correlation analyses to define SPHK1’s immune modulation and biomarker potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-emerging-role-of-sphk1-at-the-immune-metabolic-interface-a-pan-cancer-integrative-analysis/344744/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-emerging-role-of-sphk1-at-the-immune-metabolic-interface-a-pan-cancer-integrative-analysis/344744.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SPHK1 and why is it relevant to cancer immunity?","Question",{"text":112,"@type":113},"SPHK1 regulates sphingolipid signaling by balancing sphingosine-1-phosphate and sphingosine, which affects both cell fate and immune responses. The study frames SPHK1 as a potential metabolic immune checkpoint linking metabolic dysregulation to immune evasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SPHK1 expression analyzed across cancers?",{"text":117,"@type":113},"SPHK1 expression was analyzed using RNA-seq data from The Cancer Genome Atlas (TCGA) covering 33 cancer types, followed by clinical association analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports SPHK1 as a prognostic biomarker?",{"text":121,"@type":113},"The study reports that SPHK1 is significantly upregulated in multiple cancers and that high SPHK1 expression is consistently associated with poor patient survival, supporting its prognostic value.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344744,1790158258,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe emerging role of SPHK1 atthe immune-metabolic interface: a pan-cancer integrative analysis  \nLei Wang1,2,7, Guodong Zhong3,7, Hao Luo4, Qiao He4, Yan Chen5, Wei Li6􀀍 & Qiuju Wang4􀀍  \nCancer remains a major global health challenge, with incidence and mortality rates continuing to rise. Metabolic reprogramming, a hallmark of cancer, not only sustains rapid proliferation but also shapesan immunosuppressive tumor microenvironment. Among metabolic enzymes, sphingosine kinase 1 (SPHK1) plays a key role in sphingolipid signaling by regulating the balance between sphingosine- 1-phosphate and sphingosine. This regulation influences both cell fate and immune responses. However, the role of SPHK1 as a potential “metabolic immune checkpoint” across various cancers, as well as its implications for prognosis and immunotherapy, remains insufficiently explored. In this pan-cancer study, we analyzed SPHK1 expression using RNA-seq data from The Cancer Genome Atlas, which includes 33 cancer types. We also examined its clinical association. We then validated SPHK1 expression atthe mRNA and protein levels in clinical samples of head and neck squamous cell carcinoma (HNSC), stomach adenocarcinoma (STAD), and liver hepatocellular carcinoma (LIHC) using RT-qPCR and immunohistochemistry, and assessed its effect on cancer cell viability using the CCK-8 assay. Furthermore, we conducted integrated analyses to evaluate the relationship between SPHK1 expression and key immunological features, including immune cell infiltration, tumor mutation burden (TMB), microsatellite instability (MSI), and immune checkpoint gene expression. These analyses aimed to delineate SPHK1’s role in immune modulation. We observed significant upregulation of SPHK1 in multiple cancers, especially in HNSC, STAD, and LIHC. We also confirmed its ability to enhance cancer cell viability. High SPHK1 expression is consistently associated with poor patient survival, supporting its prognostic value. Importantly, comprehensive immunological analyses revealed that SPHK1 expression is closely linked to immunosuppressive features across cancers, including altered immune cell infiltration and elevated expression of established immune checkpoint molecules, positioning SPHK1 as a key regulator linking metabolic dysregulation to immune evasion. Our findings suggest that SPHK1 acts as an oncogene and prognostic biomarker. Additionally, it functions as a novel “metabolic immune checkpoint” across multiple cancer types. SPHK1 may bridge sphingolipid metabolism with tumor immune suppression and represents a potential promising integrated target for metabolically informed immunotherapy strategies.  \nKeywords SPHK1, Metabolic immune checkpoint, Cancer, Biomarker, Prognosis, Tumor microenvironment, Immunotherapy  \nAbbreviations  \nACC Adrenocortical carcinoma  \nBLCA Bladder urothelial carcinoma BRCA Breast invasive carcinoma  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma  \n1Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China. 2Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, China. 3Department of Pathology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.  \n4Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, NO. 55 South Renmin Road, Wuhou District, Chengdu 610041, Sichuan, China. 5Department of Clinical Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China. 6Department of Vascular Intervention, The People’s Hospital of Jingmen, Jingmen, Hubei, China. 7Lei Wang and Guodong Z","cbCaia2KjFInr1bU","https://ap.wps.com/l/cbCaia2KjFInr1bU","pdf",6501775,16,"English","# Background and Rationale\n# Study Design and Data Sources\n## Expression and Clinical Association\n## Experimental Validation and Viability Testing\n# Integrated Immunological Analyses\n## Immune Cell Infiltration, TMB, MSI, and Checkpoint Genes\n# Key Findings and Conclusions","[{\"question\":\"What is SPHK1 and why is it relevant to cancer immunity?\",\"answer\":\"SPHK1 regulates sphingolipid signaling by balancing sphingosine-1-phosphate and sphingosine, which affects both cell fate and immune responses. The study frames SPHK1 as a potential metabolic immune checkpoint linking metabolic dysregulation to immune evasion.\"},{\"question\":\"How was SPHK1 expression analyzed across cancers?\",\"answer\":\"SPHK1 expression was analyzed using RNA-seq data from The Cancer Genome Atlas (TCGA) covering 33 cancer types, followed by clinical association analyses.\"},{\"question\":\"What evidence supports SPHK1 as a prognostic biomarker?\",\"answer\":\"The study reports that SPHK1 is significantly upregulated in multiple cancers and that high SPHK1 expression is consistently associated with poor patient survival, supporting its prognostic value.\"}]","The emerging role of SPHK1 at the immune-metabolic interface - a pan-cancer integrative analysis | PDF",1790055132,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cff5fd19f4a7d1d17907fd9d45d523e3.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e7aaa6dbe47b815e6a227e7273ce04e.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce4bf33c573944ce049d0e5e19957a3a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34e69628838d5d93f6f90d5f5190b7f4.webp",980,1287]